Company intelligence / Profile preview

Xi'an Xintong Medicine Research

Xi'an, Shaanxi, China

Ownership: Private
Employees: ~180
Development stage: Other

Overview

Xintong Pharmaceutical is a China-based biopharmaceutical company specializing in the development of innovative small molecule drugs for liver diseases, including chronic hepatitis B and liver cancer. The company utilizes its proprietary HepDirect technology platform, licensed from Ligand Pharmaceuticals, to create liver-targeted prodrugs that enhance therapeutic efficacy while reducing systemic toxicity. Its lead product, pradefovir mesylate, was approved by the NMPA in 2024 for the treatment of chronic hepatitis B. Xintong is also advancing clinical candidates for hepatocellular carcinoma and amyotrophic lateral sclerosis, and is listed on the Shanghai Stock Exchange's STAR Market.

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Ligand Pharmaceuticals

Beyond the preview

Go deeper on Xi'an Xintong Medicine Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xi'an Xintong Medicine Research.

Explore the full profile